The risks of pharmacological therapy for insomnia (part 2): update for the clinical nurse specialist.
O'Malley
Patricia
P
Center for Nursing Excellence, Miami Valley Hospital, Dayton, Ohio 45409, USA. pomalley@mvh.org
D000328:Adult; D015897:Comorbidity; D016903:Drug Monitoring / Q000451:nursing; D011307:Drug Prescriptions; D019317:Evidence-Based Medicine; D006207:Half-Life; D006305:Health Status Indicators; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000145:classification / Q000378:metabolism / Q000627:therapeutic use; D008019:Life Style; D008487:Medical History Taking; D009720:Nurse Clinicians / Q000458:organization & administration; D024802:Nurse's Role; D009730:Nursing Assessment; D010353:Patient Education as Topic; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy / Q000209:etiology / Q000451:nursing; D014481:United States; D014486:United States Food and Drug Administration
D006993:Hypnotics and Sedatives